Lonser Russell R, Wait Scott D, Butman John A, Vortmeyer Alexander O, Walther McClellan M, Governale Lance S, Oldfield Edward H
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892-1414, USA.
J Neurosurg. 2003 Jul;99(1 Suppl):64-9. doi: 10.3171/spi.2003.99.1.0064.
Hemangioblastomas in the lumbosacral region are rare, and the authors of prior reports have not defined the surgical management, histopathological features, or outcome in a group of patients after resection of these tumors. To identify features that will help guide the operative and clinical management of these lesions, the authors reviewed data obtained in a series of patients with von Hippel-Lindau syndrome who underwent resection of lumbosacral nerve root hemangioblastomas.
Six consecutive patients (three men and three women; mean age at surgery 39 years [range 31-48 years]) who underwent operations for resection of lumbosacral nerve root hemangioblastomas were included in this study. The mean follow-up period was 23 months (range 6-45 months). Data derived from examination, hospital charts, operative findings, histopathological analysis, and magnetic resonance imaging were used to analyze surgical management and clinical outcome. The resected tumors were located in the lumbar (five cases) or sacral (one case) regions; the mean tumor size was 2728 mm3 (range 80-15,022 mm3). Consistent with central nervous system (CNS) regional variation of space available to accommodate the neural compressive effect of the hemangioblastoma size, the mean tumor volume (2728 mm3) of these symptomatic lesions was much larger than that of symptomatic hemangioblastomas resected in the other regions of the CNS. Histopathological examination showed infiltration of the associated nerve root by the hemangioblastoma in each case. In five of the six patients complete resection was achieved, and in one patient intradural exploration of two hemangioblastomas was performed, but resection was not achieved because of motor root involvement. In all cases involving complete resections the patients experienced symptomatic improvement.
Lumbosacral nerve root hemangioblastomas can be safely removed in most patients with von Hippel-Lindau syndrome. Generally, hemangioblastomas of the lumbosacral nerve roots should be resected when they become symptomatic. Because these neoplasms appear to originate from the nerve root, it is necessary to sacrifice the nerve root from which the hemangioblastoma originates to achieve complete resection.
腰骶部血管母细胞瘤较为罕见,既往报告的作者未对一组切除这些肿瘤后的患者的手术治疗、组织病理学特征或预后进行界定。为了确定有助于指导这些病变手术及临床管理的特征,作者回顾了一系列患有冯·希佩尔-林道综合征且接受了腰骶神经根血管母细胞瘤切除术的患者所获得的数据。
本研究纳入了连续6例接受腰骶神经根血管母细胞瘤切除术的患者(3例男性和3例女性;手术时平均年龄39岁[范围31 - 48岁])。平均随访期为23个月(范围6 - 45个月)。来自检查、医院病历、手术发现、组织病理学分析和磁共振成像的数据用于分析手术治疗和临床结果。切除的肿瘤位于腰椎(5例)或骶骨(1例)区域;平均肿瘤大小为2728 mm³(范围80 - 15022 mm³)。与中枢神经系统(CNS)区域可用于容纳血管母细胞瘤大小对神经压迫效应的空间变化一致,这些有症状病变的平均肿瘤体积(2728 mm³)远大于在CNS其他区域切除的有症状血管母细胞瘤。组织病理学检查显示,每例患者的相关神经根均有血管母细胞瘤浸润。6例患者中有5例实现了完全切除,1例患者对两个血管母细胞瘤进行了硬膜内探查,但由于运动神经根受累未实现切除。在所有实现完全切除的病例中,患者的症状均有改善。
大多数患有冯·希佩尔-林道综合征的患者可安全切除腰骶神经根血管母细胞瘤。一般来说,腰骶神经根血管母细胞瘤出现症状时应予以切除。由于这些肿瘤似乎起源于神经根,为实现完全切除,有必要牺牲血管母细胞瘤起源的神经根。